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Abstract
Multiple testing is a problem in genome-wide or region-wide association studies. In this report, we
consider a study design given by the Genetic Analysis Workshop 15 (GAW15) Problem 3 – nuclear
families (parents with their affected children) and unrelated controls. Based on this design, we
propose three two-stage approaches to deal with the problem of multiple testing. The tests in the
first stage, statistically independent of the association test used in the second stage, are used to
screen or select single-nucleotide polymorphisms (SNPs). Then, in the second stage, a family-based
association test is performed on a much smaller set of selected SNPs. Thus, the problem of multiple
testing is much less severe. Our simulation studies and application to the dense SNP data of
chromosome 6 in the GAW15 Problem 3 show that the two-stage methods are more powerful
than the one-stage method (using the family-based association test only).
Background
Genome-wide or region-wide association is a promising
approach to mapping complex disease genes [1,2]. How-
ever, the success of genome-wide or region-wide associa-
tion studies will depend on whether the information gain
of increased number of single-nucleotide polymorphisms
(SNPs) will be diluted by the multiple-comparison prob-
lem [3]. When tens or hundreds of thousands of SNPs are
tested for association, the p-values need to be adjusted for
controlling type I error rates. Most multiple-testing adjust-
ment approaches, including Bonferroni correction for
controlling the family-wise error rate and the method pro-
posed by Benjamini and Hochberg [4] for controlling the
false discovery rate (FDR), become more conservative as
more tests are done.
In case-control studies, several authors have proposed a
two-stage design that utilizes two independent samples
[5,6]. The first sample is used to screen and select SNPs for
association tests. The association tests are conducted on
the selected SNPs by using the second sample, so that the
number of association tests is diminished and the correc-
tion for multiple testing is less severe. Recently, in map-
ping quantitative trait loci using family data, Van Steen et
al. [3] proposed an interesting approach that performs the
SNP screening and association test using the same sample.
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The basic idea of Van Steen et al.'s method is that the
screening test based on the traits and between-family gen-
otype scores is statistically independent of the association
test that depends on trait values and within-family geno-
type scores. The screening test is used first to select SNPs,
and the association test is performed on a much smaller
set of selected SNPs. Unfortunately, the same idea cannot
be applied to family-based analyses for qualitative traits.
In this article, we propose several two-stage methods to
test association for qualitative traits by using nuclear fam-
ilies (including parental phenotypes) or nuclear families
and unrelated controls. To analyze the data set of nuclear
families, we compare the allele frequency in affected par-
ents with that of unaffected parents (test I) to screen and
select SNPs. Then the pedigree disequilibrium test (PDT)
[7] is used to perform the association test on the selected
SNPs by comparing the alleles that are transmitted to the
children with those that are not transmitted. To analyze
the data set that contains nuclear families and unrelated
controls, as the data set in the GAW15 Problem 3, we pro-
pose two methods to screen SNPs. One is comparing the
allele frequency in parents with that in unrelated controls
(test II). The other is a combination of test I and II. All the
proposed screening tests are independent of the associa-
tion test, that is, the PDT. Furthermore, because a signifi-
cant association only depends on the results of the PDT,
the proposed two-stage approaches are robust to popula-
tion admixture. We compare the performance of the pro-
posed methods by using PDT alone through simulation
studies and analysis of the data set of the GAW15 Problem
3. Our simulation and the GAW15 data analysis results
show that the three proposed two-stage methods have cor-
rect type I error rates and, in most cases, are more power-
ful than the PDT.
Methods
Consider a sample of n nuclear families and N unrelated
controls. Suppose that we have genotyped M  markers
across the genome or in a candidate region for each sam-
pled individual. Also, all children in the nuclear families
are affected and the disease status of the parents is availa-
ble. The reason for considering this kind of sample is the
design of the GAW15 Problem 3 data set. To detect disease
susceptibility loci, based on the sample structure, we pro-
posed three methods. All three methods are two-stage
approaches – the methods in the first stage are used to
screen and select SNPs and those in the second stage are
used to test the association on the selected SNPs.
The three approaches we propose for the first stage are
based on a test statistic for a case-control study. Consider
a case-control study with N1 cases and N2 controls, and
each sampled individual has a genotype at a bi-allelic
marker with two alleles A and a. To test the association
between the marker and the disease, one can use the sta-
tistic:
where   and   are the sample frequencies of allele A in
cases and controls, respectively;
 is the estimate of the vari-
ance of   -  ; p0 is the sample allele frequency of allele A
in the whole sample. Under the null hypothesis of no
association, this test statistic asymptotically follows a
standard normal distribution. When the absolute value of
T is large, we reject the null hypothesis of no association.
Based on the test statistic T, we propose the following
three tests that can be used in the first stage to screen
SNPs:
1. Consider affected parents of the sampled nuclear fami-
lies as cases and unaffected parents of the sampled nuclear
families as controls. The test statistic T based on this sam-
ple is denoted by Tcc. The Tcc only uses the nuclear families
(does not need the unrelated controls).
2. Consider all the parents of the n sampled nuclear fam-
ilies as cases and the N sampled unrelated controls as con-
trols. The test statistic T based on this sample is denoted
by Tpc. If A is a high risk allele, the frequency of A among
the parents should be higher than that in the controls,
because each pair of parents has at least one affected child.
3. The third approach is a combination of the Tpc and Tcc.
The test statistic of this approach is Fisher's combination
of the p-values of the two tests and is given by Tcb = -2(log
P1 + log P2), where P1 and P2 are the p-values of the tests Tpc
and  Tcc, respectively. Under the null hypothesis of no
association, Tcb will follow a χ2 distribution with 4 degrees
of freedom [8].
We use the PDT [7] to test association in the second stage.
Suppose there are ni affected children in the ith family.For
a biallelic marker with two alleles A and a, we code the
three genotypes aa, Aa, and AA as 0, 1, and 2, respectively.
Let Xij, XiF, and XiM denote the codes of the genotypes of
the  jth child, father, and mother in the ith family. Let
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, ,  and
.
Then the test statistic of the PDT is given by  .
Under null hypothesis of no association, the PDT follows
the standard normal distribution.
When we apply the two-stage approaches, we first apply
one of Tpc, Tcc, or Tcb to each of the M markers and get M p-
values. Select L markers with the smallest p-values (we will
discuss later how to choose L). Then, we apply the PDT to
the L selected SNPs, and declare a SNP as significant if the
p-value of the PDT at this marker is less than a threshold
δLα . The threshold δLα is determined by controlling the
FDR, the ratio of the number of falsely rejected null
hypotheses to the total number of rejected null hypothe-
ses, at level α. To control the FDR we can choose the cut-
off δLα as follows [4]: let p(1),...,p(L) be the ordered p-values
when we apply the PDT to the L selected markers, then
.
In our simulation studies and application to analyze the
GAW15 simulated data, we use the following method to
calculate the power of the two-stage test to detect one dis-
ease locus, say locus D. Suppose that there are K replicated
samples. Let k denote the number of samples in which
locus D is selected in the first stage and the p-value of locus
D in the second stage is less than δLα . Then, the power to
detect Locus D is k/K.
Results
Simulated data
We first evaluate the FDR under null the hypothesis of no
marker associated with disease. Under the null hypothe-
sis, the FDR and the family-wise type I error rate will be
the same. We also evaluate the statement of the independ-
ence between the tests in the first stage and the PDT in the
second stage. For these purposes, we generate genotypes
for each individual at 100 SNPs. For a given rare allele fre-
quency, we generate the genotypes of the parents of the
nuclear families and unrelated controls by assuming
Hardy-Weinberg equilibrium and independence between
markers. Each of the parents randomly transmits one of
the two alleles to a child to form the child's genotype. We
consider two different sample sizes, two different rare
allele frequencies, and two different numbers of children
in each family. For each simulation scenario, we generate
1000 samples to estimate the FDR at nominal level 0.05.
For each of the two-stage approaches, we use a threshold
α to select SNPs in the first stage, that is, we select all SNPs
whose p-values are less than α. We choose several values
for the threshold. If a two-stage approach has a correct
FDR, we know that the tests used in the first stage and in
the second stage should be independent. The results are
summarized in Table 1. Table 1 shows that the FDRs of
the three two-stage approaches are very consistent with
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Table 1: Estimated type I error rates at nominal level 0.05, 1000 replicate simulation data sets
Two children in each familyb One child in each familyb
Sample size Minor allele frequency αa PDT Tpc Tcc Tcb PDT Tpc Tcc Tcb
100 families, 120 controls 0.1 0.05 0.014 0.032 0.043 0.042 0.031 0.033 0.044 0.043
0.1 0.023 0.028 0.032 0.029 0.041 0.029
0.2 0.025 0.027 0.027 0.031 0.031 0.026
0.3 0.05 0.024 0.042 0.049 0.047 0.036 0.05 0.045 0.053
0.1 0.04 0.043 0.035 0.051 0.047 0.046
0.2 0.046 0.038 0.037 0.054 0.047 0.053
500 families, 600 controls 0.1 0.05 0.048 0.051 0.051 0.059 0.053 0.052 0.054 0.051
0.1 0.04 0.052 0.042 0.052 0.041 0.045
0.2 0.042 0.046 0.044 0.04 0.047 0.05
0.3 0.05 0.059 0.053 0.047 0.045 0.042 0.046 0.04 0.042
0.1 0.054 0.042 0.046 0.048 0.034 0.044
0.2 0.053 0.034 0.048 0.047 0.043 0.041
aα, the cut-off p-value of the test in the first stage
bPDT, pedigree disequilibrium test; Tpc, test comparing all parents to controls; Tcc, test comparing affected and unaffected parents; Tcb, combined Tpc 
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the nominal level, especially when the sample size is large
or the minor allele frequency is large (>0.1). The FDR of
the one-stage test PDT is slightly conservative for a small
sample size. When the sample size is large (>100 families
and 120 controls), the FDRs of the PDT are also very con-
sistent with the nominal level.
GAW15 data analysis
We applied three two-stage approaches and the PDT to
analyze the dense SNP data of chromosome 6 in the
GAW15 Problem 3 (simulated rheumatoid arthritis data).
The data contain 100 replicate data sets. In each replicate
data set, there are 1500 nuclear families, 2000 unrelated
controls and two affected children in each family. Each
individual has genotypes at 17,820 SNPs on chromosome
6. From the answer provided with the data set, we know
that there are three trait loci: Locus DR, Locus C, and
Locus D on chromosome 6. Locus DR affects the risk of
rheumatoid arthritis (RA). Locus C increases RA risk only
in women. These two loci are in the same position. The
typed SNP 3437 on chromosome 6 is in the same position
as Locus DR and Locus C, that is, the recombination rates
between SNP 3437 and Locus DR and between SNP 3437
and Locus C are both zero. The rare allele of Locus D
increases RA risk five-fold. In the dense SNP panel of chro-
mosome 6, the SNP that is nearest to Locus D is SNP
3917. The genetic distance between locus D and SNP
3917 is 0.00171 cM, and the physical distance is 1565 bp.
We first compare the power of the four methods to detect
SNP 3437. The association between SNP 3437 and RA
turns out to be very strong, such that the power of the four
methods is all 100%. In order to do the power compari-
son, we reduce the sample size and, instead of detecting
SNP 3437, we detect SNP 3455. SNP 3437 and SNP 3455
are in linkage disequilibrium with r = 0.36 and D' = 0.45.
The results of the power comparison for detecting SNP
3455 using a smaller sample size are summarized in Table
2. The results show that the two-stage approaches Tpc and
Tcb, which use both family data and unrelated controls, are
more powerful than the PDT, especially when α is 1%,
5%, or 10%. However, the two-stage approach Tcc is not as
powerful as the PDT when α is less than 0.3. When α is
between 0.5 and 0.8, the Tcc is slightly more powerful than
the PDT (results not shown).
The power of the four methods to detect SNP 3917 is sum-
marized in Table 3. Because the power of all four methods
is not very high, we doubled the sample size by merging
two replicate data sets together as one sample. The results
Table 3: Power for detecting marker 3917 based on the dense SNP data of chromosome 6 by merging two replicate data sets to 
increase sample size
Two children in each familyb One child in each familyb
αa PDT Tpc Tcc Tcb PDT Tpc Tcc Tcb
0.01 0.36 0.22 0.44 0.24 0.18 0.32
0.05 0.56 0.32 0.68 0.4 0.28 0.52
0.1 0.56 0.54 0.42 0.68 0.3 0.42 0.36 0.54
0.3 0.58 0.54 0.64 0.32 0.28 0.32
0.5 0.62 0.56 0.64 0.34 0.28 0.34
aα, the cut-off p-value of the test in the first stage
bPDT, pedigree disequilibrium test; Tpc, test comparing all parents to controls; Tcc, test comparing affected and unaffected parents; Tcb, combined Tpc 
and Tcc
Table 2: Power for detecting SNP 3455 based on the dense SNP data of chromosome 6 by using 150 families and 200 unrelated 
controls
Two children in each familyb One child in each familyb
αa PDT Tpc Tcc Tcb PDT Tpc Tcc Tcb
0.01 0.93 0.15 0.96 0.66 0.13 0.87
0.05 0.95 0.39 0.96 0.65 0.29 0.8
0.1 0.83 0.96 0.54 0.96 0.53 0.64 0.4 0.75
0.3 0.91 0.77 0.91 0.58 0.53 0.61
0.5 0.88 0.81 0.88 0.56 0.54 0.56
aα, the cut-off p-value of the test in the first stage
bPDT, pedigree disequilibrium test; Tpc, test comparing all parents to controls; Tcc, test comparing affected and unaffected parents; Tcb, combined Tpc 
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in Table 3 show that, in the case of one child in each fam-
ily, all three two-stage approaches are more powerful than
the PDT when α > 0.05. When the value of α is between
0.05 and 0.1, the Tcb is much more powerful than the PDT.
In the case of two children in each family, the Tcb is also
more powerful than the PDT when α > 0.01. The other
two two-stage approaches, the Tpc and Tcc, are only slightly
more powerful than the PDT when α ≥ 0.05.
Discussion
In this report for genome-wide or region-wide association
studies, we proposed three two-stage approaches to ana-
lyze family data or data sets that contain family data as
well as unrelated controls. Based on our simulation stud-
ies and applications of the data sets of the GAW15 Prob-
lem 3, we are able to demonstrate that, in the case of one
child in each family – the typical data set of the TDT
design – all three two-stage approaches are more powerful
than the PDT. In almost all the cases we considered, the
Tcb using family data and unrelated controls is more pow-
erful than the PDT, and in several cases the Tcb can double
the power of the PDT. How to choose the value of the
threshold α is a problem. From our simulation studies,
one can see that the value of α around 0.01 may be a good
choice for the Tpc and Tcb. If only the family data are avail-
able, we would use the two-stage approach Tcc. In the case
of one child, the value around 0.1 may be a good choice
for α. In the case of two children, the Tcc does not benefit
much. In general, we need further investigation for choos-
ing the value of α.
Conclusion
Our simulation and the GAW15 data analysis results
show that the three proposed two-stage methods have cor-
rect type I error rates and, in most cases, are more power-
ful than the PDT.
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